VISION & MISSION
We are committed to making lives better with medicines that precisely edit RNA.
Our vision: To harness advances in genetics to develop medicines that improve human health.
Our mission: To be the leading RNA editing company delivering precision therapies to patients with rare and common diseases.
“At AIRNA, we are developing potent RNA editing therapeutics to offer more hope to patients who currently have limited options. The passion, dedication, and wealth of knowledge of our team, combined with the data we have generated, makes me very confident in our approach.”
Victor De Jesus
Associate Scientist
“As someone whose life was transformed by medical breakthroughs, it’s a privilege to be part of a company that is pioneering RNA editing to serve patients with unmet need.”
Sruthi V. Hindupur
Senior Scientist
Rodger Novak, MD
Board Chair
Arch Venture Partners
Forbion
Venrock
RTW
Nextech
ND Capital
Cambria Alpha-Cobb, JD, PhD
Head of Intellectual Property
Robert Altshuler, PhD
Director, Bioinformatics
Kevin Baker, PhD
Senior Scientist, Toxicology
Namita Bisaria, PhD
Head of Research Strategy and Operations
Peter Borsos
Research Associate
Elisangela Bressan, PhD
Senior Scientist
Josh Brumm
Forbion
Maegan Brunelle
Accounting Manager
Martina Buttschardt
Research Associate
Li-Hao Chang
Scientist
Aindrila Chatterjee, PhD
Senior Scientist
Chien-Ju Chen, PhD
Senior Scientist
Charles Conover, PhD
Vice President, Program Management
Arthur de Garidel-Thoron, JD
Head of Business Development
Victor De Jesus
Associate Scientist
Anand Deshpande
Director, GxP Quality Assurance
Allison Dorval
Chief Financial Officer
Eva-Maria Duerr, PhD
Senior Scientist
Jacob S. Elkins, MD
Chief Medical Officer
Kris Elverum
President and Chief Executive Officer
Kris Elverum
President and Chief Executive Officer, AIRNA
Juri Eyberg, PhD
Senior Scientist
Kat Feldmann
Senior Executive Assistant
Lena Fischer
Vice President, Finance & Operations
Patrick Foster, PhD
Head of CMC
Ina Gerber
Associate Director, HR & Finance
Veronica Giachin
Research Associate
Hyun Gyung Jang, PhD
Director DMPK & Clinical Pharmacology
Sruthi V. Hindupur, PhD
Senior Scientist
Heather Hirsch, PhD
SVP, Translational Sciences
Laleh Jafarpour, PhD
Associate Director, CMC
Inga Jarmoskaite, PhD
Senior Scientist
Tamara Joseph, JD
Chief Legal Officer
Sean Kendall, MS
ARCH Venture Partners
Robin Klimek, PhD
Senior Scientist
Kaiko Kunii
In Vivo Pharmacologist
Jin Billy Li, PhD
Stanford University
Konstantin Licht, PhD
Senior Scientist
Dirk Lindenblatt, PhD
Senior Scientist
Aline Mack
Research Associate
Kristyn McCandless, JD
Associate Director, Legal
Tobias Merkle, PhD
Vice President, Platform
Daniella Mizurini, PhD
Associate Principal Scientist
Melissa McCracken, PhD
Nextech
Jürgen Müller, PhD
Managing Director Tübingen and Head of Chemistry
Negin Namazian
Senior Research Associate
Angelika Oswald, PhD
Scientist
Damla Ozen
Head of IT
Aakash Parikh
Lab Manager
Maria Popovici-Muller
Senior Research Associate
Elena Poser, PhD
Principal Scientist
Edgar Ramos
Financial Controller
Fernanda Sachenbacher, PhD
Senior Scientist
Lange Yakubu Saleh, PhD
Scientist
Sriram Sathy, PhD
Chief Scientific Officer
Carolin Schlitz
Research Associate
Anindya Sen, PhD
Vice President, Preclinical Development
Devyn Smith, PhD
Arbor Bio
Luise Stafforst, PhD
Senior EHS & QC Analyst
Thorsten Stafforst, PhD
University of Tübingen
Thorsten Stafforst, PhD
University of Tübingen
Kristina Storey
SVP, Head of Regulatory Affairs
Niru Subramanian
Chief Operating Officer
Stephen Su, PhD
Senior Director, Target Validation
Rewati Tappu, PhD
Senior Scientist
Colleen Tucker, MS
Head of People
Manvi Upadhyay
Senior Research Associate
Paul Vogel, PhD
Vice President, Discovery
Paul Vogel, PhD
Vice President, Discovery
Christopher Volkert
Senior Research Associate
Joyce Zhao, PhD
Director, Analytical Development